Viking Therapeutics, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Material agreementSep 28 →Insiders1 insider bought $149,912 in 1 open-market buy. 5 insiders sold $16.0M, 0 of 17 sales on a 10b5-1 plan.→HoldersFMR 5.4%BlackRock 5.3%State Street 4.8%→Financing →PeersClosest companies: MBX, ORIC, ALGS→
From the filings
Figures
- Revenue
- $0.00last 12 months
- Net income
- −$534.8Mlast 12 months
- Operating cash flow
- −$340.3Mlast 12 months
- Cash and equivalents
- $125.8Mat the last balance sheet
- Shares outstanding
- 116.7M shareson issue